Hedgehog pathway and cancer: A new area (Review)

Oncol Rep. 2024 Sep;52(3):116. doi: 10.3892/or.2024.8775. Epub 2024 Jul 12.

Abstract

In years of research on classical pathways, the composition, information transmission mechanism, crosstalk with other pathways, and physiological and pathological effects of hedgehog (HH) pathway have been gradually clarified. HH also plays a critical role in tumor formation and development. According to the update of interpretation of tumor phenotypes, the latest relevant studies have been sorted out, to explore the specific mechanism of HH pathway in regulating different tumor phenotypes through gene mutation and signal regulation. The drugs and natural ingredients involved in regulating HH pathway were also reviewed; five approved drugs and drugs under research exert efficacy by blocking HH pathway, and at least 22 natural components have potential to treat tumors by HH pathway. Nevertheless, there is a deficiency of existing studies. The present review confirmed the great potential of HH pathway in future cancer treatment with factual basis.

Keywords: cancer; hedgehog; phenotype; signaling pathway.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Hedgehog Proteins* / genetics
  • Hedgehog Proteins* / metabolism
  • Humans
  • Mutation
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Neoplasms* / metabolism
  • Neoplasms* / pathology
  • Signal Transduction* / drug effects

Substances

  • Hedgehog Proteins
  • Antineoplastic Agents

Grants and funding

The present study was supported by the Zhejiang Provincial Natural Science Foundation of China (grant no. LQ22H270008), the National Natural Science Foundation of China (grant no. 82204824), the Scientific Research Fund of Zhejiang Provincial Education Department (grant no. Y202351288), the Young Elite Scientists Sponsorship Program by China Association of Chinese Medicine (grant no. 2021-QNRC2-B13) and the Hangzhou Medical and Health Science and Technology Project (grant no. A20230054).